1992•European Journal of Pharmacology Molecular PharmacologyRequires access

The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography

Philip Seeman, Hong‐Chang Guan, Olivier Civelli, Hubert H.M. Van Tol, Roger K. Sunahara, Hyman B. Niznik

Open publisher page 66 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 66 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Raclopride, Spiperone, Dopamine, Dopamine receptor D2, Dopamine receptor, Receptor, Internal medicine, Endocrinology

Back to paper search Browse research topics Original source

The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography — Research Paper | ScholarLens